trial · primary record
ARX517
Metastatic Prostate Cancer
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 183 |
| Primary completion | 2026-12-31 |
| Primary endpoint | Assess incidence of adverse events |
| Registry ID | NCT04662580 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:48.544Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04662580
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.